Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Role for PARS and Thrombin-Gpibα Interaction for Thrombin Induced Procoagulant Platelet Formation

Morgane Bourcy, PhD, Leonardo Pasalic, MBBS, BSc, Samuel Wang, Heather Campbell, BSc, Hai Po Helena Liang, PhD, Vivien Chen, PhD FRACP, FRCPA, MBBS

Blood (2017) 130 (Supplement 1): 3607.

https://doi.org/10.1182/blood.V130.Suppl_1.3607.3607

Published: 2017

Journal Articles

Beneficial Effect of Exogenous PF4 on SRA for Detecting Pathogenic HIT Antibodies

Caroline Vayne, Jérome Rollin, PhD, Eve Anne Guery, Claire Kizlik-Masson, Anne Bauters, Pharm D, Yves Gruel, MD, Claire Pouplard, Pharm D, PhD

Blood (2016) 128 (22): 3733.

https://doi.org/10.1182/blood.V128.22.3733.3733

Published: 2016

Journal Articles

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Hiroshi Okamura, MD, Mitsutaka Nishimoto, MD,PhD, Takahiko Nakane, MD, PhD, Hideo Koh, MD,PhD, Yasuhiro Nakashima, MD, PhD, Yasunobu Takeoka, MD, PhD, Mika Nakamae, MD,PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD, Hirohisa Nakamae, MD PhD

Blood (2016) 128 (22): 5755.

https://doi.org/10.1182/blood.V128.22.5755.5755

Published: 2016

Journal Articles

How I treat patients with a history of heparin-induced thrombocytopenia

Theodore E. Warkentin, Julia A. M. Anderson

Blood (2016) 128 (3): 348–359.

https://doi.org/10.1182/blood-2016-01-635003

Published: 2016

Journal Articles

A Humanized Anti FcγRIIa Scfv Inhibits Platelet Activation, Aggregation and Thrombus Formation in Heparin-Induced Thrombocytopenia (HIT)

Jose Perdomo, PhD, Jaa Yien New, PhD, Zohra Ahmadi, Xing-Mai Jiang, PhD, Beng H Chong, MBBS, PhD

Blood (2015) 126 (23): 10.

https://doi.org/10.1182/blood.V126.23.10.10

Published: 2015

Journal Articles

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study

Lori-Ann Linkins, Shannon M. Bates, Agnes Y. Y. Lee, Nancy M. Heddle, Grace Wang, Theodore E. Warkentin

Blood (2015) 126 (5): 597–603.

https://doi.org/10.1182/blood-2014-12-618165

Published: 2015

Journal Articles

Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study

Matthew Kang, Majed Alahmadi, Sonja Sawh, Michael J. Kovacs, Alejandro Lazo-Langner

Blood (2015) 125 (6): 924–929.

https://doi.org/10.1182/blood-2014-09-599498

Published: 2015

Includes: Supplemental data

Journal Articles

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

Prajwal Dhakal, M.B.B.S, Vijaya R. Bhatt, MBBS

Blood (2014) 124 (21): 4265.

https://doi.org/10.1182/blood.V124.21.4265.4265

Published: 2014

Journal Articles

Beneficial Effect Of Anticoagulants In The Management Of Patients With Acute Promyelocytic Leukemia (APL): Results Of a Multicenter, Retrospective Epidemiologic Study Of The Disseminated Intravascular Coagulation Patients In Japan

Kazuo Kawasugi, MD, PhD, Tadashi Yamamoto, MD, Naoki Shirafuji, MD, PhD, Takayuki Ikezoe, MD. PhD, SungGi Chi, Yoshitaka Ogino, MD, Naoki Takezako, MD, PhD

Blood (2013) 122 (21): 2373.

https://doi.org/10.1182/blood.V122.21.2373.2373

Published: 2013

Journal Articles

Combination Of 4T’s Score and Rapid Gel Centrifugation Assay Excludes HIT In a Prospective Cohort Study

Lori Ann Linkins, MD, MSc, FRCPC, Shannon M. Bates, MD, Agnes Y.Y. Lee, MD, MSc, FRCPC, Theodore E. Warkentin, MD

Blood (2013) 122 (21): 3535.

https://doi.org/10.1182/blood.V122.21.3535.3535

Published: 2013

Journal Articles

Fondaparinux Versus Argatroban and Danaparoid for the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia: A Propensity Score Analysis.

Matthew Kang, MD, Majed Alahmadi, MD, Sonja Sawh, BScPharm, Michael J. Kovacs, MD, Alejandro Lazo-Langner, MD, MSc

Blood (2012) 120 (21): 2262.

https://doi.org/10.1182/blood.V120.21.2262.2262

Published: 2012

Journal Articles

Systematic Review of Antiphospholipid Syndrome and Left Ventricular Thrombus

David S Kotlyar, MD, Iosif Kelesidis, MD, Sofya Pintova, MD, Aarti Bhardwaj, MD, Amala Chirumamilla, MD, Per Sommer, MD, Mark A Menegus, MD, Robert J Ostfeld, MD

Blood (2010) 116 (21): 3182.

https://doi.org/10.1182/blood.V116.21.3182.3182

Published: 2010

Journal Articles

Platelet Microparticle Generation Assay: a Valuable and Simpler Alternative to 14C-SRA for Type-II HIT Diagnosis.

François Mullier, Nicolas Bailly, Yvan Cornet, Severine Robert, Jean-Claude Osselaer, Christian Chatelain, Ismail Elalamy, Jean-Michel Dogné, Bernard Chatelain

Blood (2010) 116 (21): 1442.

https://doi.org/10.1182/blood.V116.21.1442.1442

Published: 2010

Journal Articles

The Efficacy of Prophylactic Use of Antithrombin with Unfractionated Heparin or Danaparoid Sodium to Prevent Venous Thromboembolism In Children with Acute Lymphoblastic Leukemia

Hirotoshi Sakaguchi, MD, Nao Yoshida, MD, PhD, Kimikazu Matsumoto, MD, PhD, Koji Kato, MD, PhD

Blood (2010) 116 (21): 2123.

https://doi.org/10.1182/blood.V116.21.2123.2123

Published: 2010

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

Journal Articles

Danapaloid Is Significantly Effective for the Prophylaxis of Hepatic Veno-Occlusive Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of 85 Children with Hematological Malignancies.

Hirotoshi Sakaguchi, MD, Sayoko Doisaki, MD, Nao Yoshida, MD, Hideki Muramatsu, MD, Nobuhiro Watanabe, MD., PhD, Kimikazu Matsumoto, MD., PhD, Koji Kato, MD., PhD

Blood (2008) 112 (11): 1122.

https://doi.org/10.1182/blood.V112.11.1122.1122

Published: 2008

Journal Articles

The Cost of HIT-Safe Anticoagulant Use at a Tertiary Care, Adult, Academic Hospital.

Natasha Nanwa, MSc, Nicole Mittmann, MSc, PhD, Sandra Knowles, BScPhm, Claudia Bucci, BScPhm, PharmD, Rita Selby, MBBS, FRCPC, Neil Shear, MD, FRCPC, Scott Walker, MScPhm, William H. Geerts, MD, FRCPC

Blood (2008) 112 (11): 1293.

https://doi.org/10.1182/blood.V112.11.1293.1293

Published: 2008

Journal Articles

Predictive Factors for Poor Outcome in Danaparoid-Treated HIT-Patients: A French Multicentre Case-Control Study.

IsmaïL. Elalamy, B. Tardy-Poncet, A. Mulot, E. DeMaistre, Claire Pouplard, Philippe Nguyen, M. Trossaert, Y. Blanloeil, B. Cleret, Yves Gruel, MD, T. Lecompte, B. Tardy

Blood (2008) 112 (11): 1984.

https://doi.org/10.1182/blood.V112.11.1984.1984

Published: 2008

Journal Articles

Adherence to Guidelines for Monitoring for Heparin-Induced Thrombocytopenia in Patients Treated with Low Molecular Weight Heparin

Maarten ten Berg, Patricia Van den Bemt, Albert huisman, PhD, Fred Schobben, Toine Egberts, Wouter Van Solinge

Blood (2008) 112 (11): 1282.

https://doi.org/10.1182/blood.V112.11.1282.1282

Published: 2008

Journal Articles

Outcome of Thrombosis in UKALL 2003- Anticoagulation and Re- Exposure to Aspariginase Is Feasible and Safe.

Amrana Qureshi, Sue Richards, Ajay J. Vora, Christopher D Mitchell, Rachel Wade, Nicholas Goulden

Blood (2008) 112 (11): 900.

https://doi.org/10.1182/blood.V112.11.900.900

Published: 2008

NARROW

Role for PARS and Thrombin-Gpibα Interaction for Thrombin Induced Procoagulant Platelet Formation

Beneficial Effect of Exogenous PF4 on SRA for Detecting Pathogenic HIT Antibodies

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

How I treat patients with a history of heparin-induced thrombocytopenia

A Humanized Anti FcγRIIa Scfv Inhibits Platelet Activation, Aggregation and Thrombus Formation in Heparin-Induced Thrombocytopenia (HIT)

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study

Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

Beneficial Effect Of Anticoagulants In The Management Of Patients With Acute Promyelocytic Leukemia (APL): Results Of a Multicenter, Retrospective Epidemiologic Study Of The Disseminated Intravascular Coagulation Patients In Japan

Combination Of 4T’s Score and Rapid Gel Centrifugation Assay Excludes HIT In a Prospective Cohort Study

Fondaparinux Versus Argatroban and Danaparoid for the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia: A Propensity Score Analysis.

Systematic Review of Antiphospholipid Syndrome and Left Ventricular Thrombus

Platelet Microparticle Generation Assay: a Valuable and Simpler Alternative to 14C-SRA for Type-II HIT Diagnosis.

The Efficacy of Prophylactic Use of Antithrombin with Unfractionated Heparin or Danaparoid Sodium to Prevent Venous Thromboembolism In Children with Acute Lymphoblastic Leukemia

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Danapaloid Is Significantly Effective for the Prophylaxis of Hepatic Veno-Occlusive Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of 85 Children with Hematological Malignancies.

The Cost of HIT-Safe Anticoagulant Use at a Tertiary Care, Adult, Academic Hospital.

Predictive Factors for Poor Outcome in Danaparoid-Treated HIT-Patients: A French Multicentre Case-Control Study.

Adherence to Guidelines for Monitoring for Heparin-Induced Thrombocytopenia in Patients Treated with Low Molecular Weight Heparin

Outcome of Thrombosis in UKALL 2003- Anticoagulation and Re- Exposure to Aspariginase Is Feasible and Safe.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only